Clinical Trials Sponsored by Neogap Therapeutics AB
Total 37 results
-
Neogap Therapeutics ABKarolinska University Hospital; CTC Clinical Trial Consultants AB; Region Västmanland and other collaboratorsRecruiting
-
Calliditas Therapeutics ABRecruitingAlport SyndromeUnited Kingdom, Spain, Czechia
-
Guard Therapeutics ABTerminatedAcute Kidney InjurySpain, United States, Germany, Canada, Czechia
-
Calliditas Therapeutics ABCompletedPrimary Biliary CirrhosisUnited States, Israel, Belgium, Germany, United Kingdom, Spain, Greece, Canada, Italy
-
Sigrid Therapeutics ABCompletedOverweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre DiabetesFinland, Sweden
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyBelgium, United Kingdom, Denmark, Finland, Sweden, Germany, Spain, Italy, Czech Republic, Netherlands
-
Diamyd Therapeutics ABTerminatedType 1 Diabetes MellitusFrance, Germany, Finland, Italy, Netherlands, Slovenia, Spain, Sweden, United Kingdom
-
Diamyd Therapeutics ABCompletedType 1 DiabetesSweden
-
Sigrid Therapeutics ABRecruitingOverweight or ObesitySlovakia, Poland, Romania
-
Calliditas Therapeutics ABCompletedType 2 Diabetes Mellitus With Diabetic NephropathyAustralia, United States, Germany, Poland, Canada, Czech Republic
-
Diamyd Therapeutics ABTerminatedType 1 Diabetes MellitusUnited States
-
Calliditas Therapeutics ABCompletedPost Polio Syndrome, PPSSweden
-
Guard Therapeutics ABCompletedAcute Kidney Injury (AKI)Germany
-
Calliditas Therapeutics ABActive, not recruitingPrimary IgA NephropathySweden
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyUnited States, Australia, Taiwan, Spain, Canada, Argentina, Belarus, Belgium, Czechia, Finland, France, Germany, Greece, Italy, Korea, Republic of, Poland, Sweden, Turkey, United Kingdom
-
Calliditas Therapeutics ABCompleted
-
Modus Therapeutics ABCompletedPlacebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of SevuparinSafety and TolerabilityUnited States
-
Diamyd Therapeutics ABCompletedLatent Autoimmune Diabetes in Adult (LADA)Sweden
-
Modus Therapeutics ABErgomedCompletedSickle-Cell DiseaseNetherlands, Oman, Jamaica, Lebanon, Bahrain, Saudi Arabia, Turkey
-
Calliditas Therapeutics Suisse SAActive, not recruitingSquamous Cell Carcinoma of Head and NeckSpain, France, United States, Germany, Italy, Poland, United Kingdom
-
Calliditas Therapeutics Suisse SAActive, not recruitingPrimary Biliary Cholangitis | Liver StiffnessUnited States, Spain, France, Australia, Israel, Canada, Switzerland, Italy, New Zealand, Germany, Poland, Greece, United Kingdom, Belgium, Austria, Czechia, Hungary, Sweden
-
Aptevo TherapeuticsAlligator Bioscience ABRecruiting
-
Rare Thyroid Therapeutics International ABEgetis Therapeutics; AnovoRxAvailableMonocarboxylate Transporter 8 Deficiency | Allan-Herndon-Dudley SyndromeUnited States
-
Modus Therapeutics ABUniversity of OxfordTerminatedMalaria, FalciparumThailand
-
Sarepta Therapeutics, Inc.Hansa Biopharma ABActive, not recruitingDuchenne Muscular DystrophySpain
-
Calliditas Therapeutics ABArchimedes Development LtdCompletedIGA NephropathySweden
-
Egetis TherapeuticsPharma Consulting Group ABCompletedAdvanced Metastatic (Stage IV) Colorectal CancerSweden, United States, Bulgaria, Denmark, Georgia, Germany, Portugal, Serbia
-
Rare Thyroid Therapeutics International ABVitaccess LtdCompletedAllan-Herndon-Dudley Syndrome | Monocarboxylate Transporter 8 (MCT8) DeficiencyUnited Kingdom
-
Karolinska InstitutetSanofi; XNK Therapeutics AB, SwedenRecruiting
-
Rare Thyroid Therapeutics International ABPremier Research Group plc; Egetis TherapeuticsRecruitingMonocarboxylate Transporter 8 Deficiency | Allan-Herndon-Dudley SyndromeUnited States, United Kingdom, Netherlands
-
Insight Therapeutics, LLCEssity Hygiene and Health ABCompletedUrinary IncontinenceUnited States
-
Rare Thyroid Therapeutics International ABErasmus Medical CenterActive, not recruitingAllan-Herndon-Dudley SyndromeUnited States, Netherlands, Czechia, Germany
-
Calliditas Therapeutics ABEurofins Optimed; York Bioanalytical SolutionCompleted
-
Karolinska InstitutetStockholm University; Sigrid Therapeutics AB, SwedenCompletedSafety Issues
-
Istanbul Medipol University HospitalSahlgrenska University Hospital, Sweden; Alanya Alaaddin Keykubat University; ScandiBio Therapeutics AB and other collaboratorsCompletedMetabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) PatientsParkinson Disease | Alzheimer DiseaseTurkey
-
ScandiBio Therapeutics ABGöteborg University; Helsinki University Central Hospital; Sahlgrenska University... and other collaboratorsUnknownNon-alcoholic Fatty Liver Disease (NAFLD)Turkey
-
ScandiBio Therapeutics ABBakirkoy Dr. Sadi Konuk Research and Training Hospital; Kanuni Sultan Suleyman... and other collaboratorsUnknown